Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






Joint Head, Stem Cells and Cancer Division
The Walter and Eliza Hall Institute of Medical Research

Professor Geoffrey Lindeman and his team identified breast stem and progenitor cells that generate all ductal tissue in the breast. His group’s discoveries helped define breast development from long-lived stem cells to progenitor and mature epithelial cells, providing a new framework for studying the molecular and cellular events that give rise to breast cancer. His group was the first to identify the culprit progenitor cell responsible for breast cancer in BRCA1 mutation carriers. In parallel, Lindeman has established a leading translational research program, made important contributions to tissue banking for cancer research, and helped advance research and clinical services in hereditary cancer.

Senior Vice President for Academic Affairs & Executive Dean
SUNY Upstate Medical University

Professor Licinio is an internationally recognised translational research leader in major depression, its biology and metabolic outcomes. His h-index is 60, with 18000 citations and publications in leading journals, such as Nature, Science, Cell, PNAS, and Lancet. He is an RANZCP Fellow with AHPRA registration as specialist in psychiatry. He is a member of the Scientific Program Committee, American Psychiatric Association, the Membership Committee, American College of Neuropsychopharmacology, and he is founding (and current) Chief Editor of three Nature Publishing Group journals: Translational Psychiatry (IF=4.36), The Pharmacogenomics Journal (IF=5.5), and Molecular Psychiatry (IF=15.147), ranked number 1 in its field worldwide.

The Doherty Institute

Professor Sharon Lewin is the inaugural director of the Doherty Institute for Infection and Immunity at the University of Melbourne; consultant physician, Alfred Hospital, Melbourne, Australia; and an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellow. She is an infectious diseases physician and basic scientist and an internationally recognised expert on HIV disease and pathogenesis. She was previously Head, Department of Infectious Diseases, The Alfred Hospital and Monash University (2003 – 2014) and Co-head, Centre for Biomedical Research, Burnet Institute (2010-2014), Melbourne, Australia.

She completed her medical training at Monash University, followed by a PhD in virology at the Burnet Institute in Melbourne and a post-doctoral fellowship at the Aaron Diamond AIDS Research Center, The Rockefeller University in New York. Her laboratory focuses on strategies to cure HIV infection, immune reconstitution following antiviral therapy and the pathogenesis of HIV-hepatitis B co-infection.

Professor Lewin has received continuous research funding from the NHMRC since 1993 and funding from the National Institutes for Health, the Wellcome Trust and the American Foundation for AIDS Research. She was the local co-chair of the XXth International AIDS Conference (AIDS2014), which was held in Melbourne July 2014, and was the largest health conference ever held in Australia. She was previously President of the Australian Society for HIV Medicine (2005-2007), is on the leadership team of the International AIDS Society’s Strategy Towards an HIV Cure and a member of the Australian Government Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmitted Infections.

Harry Perkins Institute of Medical Research

Professor Leedman is an internationally recognised physician scientist who combines academic translational cancer research and teaching, with running the Harry Perkins Institute of Medical Research and clinical endocrinology. His research has led to several key discoveries on hormone action in cancer as well as patents and company development (MiReven). He has had many senior leadership roles in H&MR, including senior NHMRC activities, Advisory Committees and Chairman of companies, such as Linear Clinical Trials Ltd. He has been recognised with awards from the Australian & UK Endocrine Societies and the WA Government for Innovator of the Year in 2013 for MiReven.

Emeritus Professor
Monash University

Professor Richard Larkins has combined clinical work in endocrinology and general medicine with research into the causes and complications of diabetes, vitamin D metabolism and other aspects of diabetes and endocrinology. As a clinical academic he was the James Stewart Professor of Medicine for 14 years and Dean of the Faculty of MDHS at the University of Melbourne for 5 years. He ceased active medical practice when he became Vice-Chancellor and President of Monash University in 2003. Other leadership positions held have included Chair of the National Health and Medical Research Council, President of the Royal Australasian College of Physicians, President of the Endocrine Society of Australia, Chair of the Accreditation Committee of the Australian Medical Council and Chair of Universities Australia. He remains active in medical and research policy as Chair of the Victorian Comprehensive Cancer Centre partnership, Chair of the Council of EMBL Aust, President of the National Stroke Foundation and Chair of the Australian Synchrotron Holding Company.

The University of Western Australia

Professor Nigel Laing is a world-renowned scientist whose work has turned Australia into an international reference centre for neuromuscular diseases. He has identified more than twenty human disease genes and has the rare honour of having a disease named after him. He established the premier diagnostic laboratory for neurogenetic disorders in Australasia, receiving patient samples from around the world.

Nigel actively engages with patient support groups, raising public understanding of medical science.

As a leader, he has been elected five times to the World Muscle Society Board, is a Member of Senate of UWA and is an awarded mentor.

Co-Director, Centre for Cancer Biology
SA Pathology and The University of South Australia

Professor Sharad Kumar’s ground-breaking work in biomedical sciences has been recognised through prestigious fellowships, national and international awards, and election to the Fellowship of the Australian Academy of Science. He has made seminal discoveries that have significantly contributed to the understanding of human diseases such as cancer, inflammation and hypertension. His publications have received extensive citations. With Angel Lopez he established the Centre for Cancer Biology, a leading research centre in South Australia. He has built collaborative teams, bringing major infrastructure funding and contributed to research community extensively through leadership, mentoring and peer review.

Senior Director, Research Therapeutic Area Lead
CSL Limited

Professor Bronwyn Kingwell’s fundamental and clinical research in arterial biomechanics has driven new approaches for the management of arterial diseases. She has pioneered the transition of detailed cellular and molecular studies of high-density lipoprotein (HDL) in laboratory models, in particular with regard to glucose metabolism, to a human context. This work has opened major new avenues in HDL therapeutics for treatment of diabetes. Her contributions have also influenced national and international physical activity guidelines. Professor Kingwell has been a leader in defining Australian science policy and is an active mentor.

Chief Executive
Melbourne Health

Although for several decades Professor Kilpatrick contributed to improving health outcomes through clinical practice and research, her key contribution and of relevance to Fellowship of the Academy has been her leadership roles in which she has ensured a strong and sustainable integration between medical research and health care delivery. This has been achieved through articulating a clear vision, relationship building and creating opportunities for integration. As CEO Royal Children’s Hospital, she has taken a lead role in establishing the Melbourne Children’s the partnership between RCH, University of Melbourne and Murdoch Children’s Research Institute, to ensure research is embedded in healthcare delivery.

Director, Centre for Future Health Systems, UNSW Sydney; Professor, Global Primary Care and Future Health Systems, University of Oxford
UNSW Sydney

Professor Michael Kidd AM is an academic general practitioner with a distinguished national and international reputation in health and medical science as a researcher, educator and medical leader. He is a highly regarded international leader in general practice and primary care, has a strong record of advocacy and public service, and has made many contributions to health policy and practice through academic positions, government appointments and professional and community service. His contributions to medical and health science include research in general practice, ehealth, health policy, education, safety and quality, and the primary care management of HIV and sexually transmissible infections.

About Fellowship with AAHMS

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.